Bosentas 62.5 Mg Tablet About
Spotlight on world-class care-Bosentas 62.5 Mg Tablet is a crackerjack, affordable solution manufactured by Cipla Ltd in India. Specially designed for superior hospital use, this round, peach-colored oral tablet is indicated for adults with pulmonary arterial hypertension (PAH). Each blister-packed strip contains ten film-coated tablets, offering precise dosage control at 62.5 mg per tablet. Shop now and experience a product crafted for reliability. Adhere to prescription guidelines and store below 25C. Bosentas ensures a trusted antihypertensive solution in a convenient, easy-to-administer form.
Specific Usage and Suitability of Bosentas 62.5 Mg Tablet
Bosentas 62.5 Mg Tablet is effectively utilized for the specific management of pulmonary arterial hypertension (PAH) in adults. Used as a superior antihypertensive agent, it works through oral administration under strict medical supervision. Carefully formulated with Bosentan (62.5mg), the round, film-coated tablets are especially suitable for adult patients in hospital settings. Follow dosage guidelines as prescribed by a physician for optimal results and safety.
Main Domestic Market Coverage and Distribution Insights
Bosentas 62.5 Mg Tablet has an expansive supply ability catering to the Indian pharmaceutical market as a leading exporter, supplier, and trader. Packing & dispatch processes ensure secure and timely delivery, adhering to cold-chain or below-25C storage needs. Estimating demand accurately allows for efficient valuation, with payment terms clearly structured for institutional clients. Each box includes one blister strip, making inventory and allocation procedures straightforward.
FAQ's of Bosentas 62.5 Mg Tablet:
Q: How should Bosentas 62.5 Mg Tablet be administered for optimal results?
A: Bosentas 62.5 Mg Tablet is administered orally, as directed by a physician. It is crucial to follow the prescribed dosage and timing to manage pulmonary arterial hypertension effectively.
Q: What is the primary benefit of using Bosentas 62.5 Mg Tablet?
A: The main benefit of Bosentas 62.5 Mg Tablet is its effectiveness in treating pulmonary arterial hypertension (PAH) in adults, helping to enhance exercise ability and delay disease progression.
Q: When should Bosentas 62.5 Mg Tablet be used?
A: Bosentas 62.5 Mg Tablet should only be used under medical supervision in hospital settings and is intended for adult patients diagnosed with pulmonary arterial hypertension.
Q: Where is Bosentas 62.5 Mg Tablet manufactured and supplied from?
A: This medication is manufactured by Cipla Ltd in India, and it is supplied, exported, and traded throughout the Indian domestic market with robust packing and distribution procedures.
Q: What is the process for obtaining Bosentas 62.5 Mg Tablet?
A: As a prescription medicine, Bosentas 62.5 Mg Tablet must be prescribed by a licensed healthcare provider. It is dispensed in hospital pharmacy settings upon validation of the prescription.
Q: How should Bosentas 62.5 Mg Tablet be stored for quality assurance?
A: To maintain its effectiveness, Bosentas 62.5 Mg Tablet should be stored below 25C as indicated on the packaging. Proper storage helps preserve the efficacy and shelf life of the product.